President & CEO, MJH Life Sciences
Sustainability: More than Meets the Eye
All the work being done to reduce the carbon footprint in conducting clinical trials circles back to the industry's overarching and ultimate goal: bringing therapies to patients faster.
A Promising Future for Oncology R&D
While recent improvement in clinical trial enrollment levels in cancer may seem modest, there are notable advancements moving the needle in expanding the pool of potential participants, as our May issue explores.
Next Steps in Digital Evolution
Exploring how the clinical trial enterprise can benefit from new advances and emerging opportunities in digital health technology.
A Need for Action
What are the necessary next steps—for all parties involved—in improving diversity in clinical trials?
The Winds of Change
The evolving role of the CRA is creating shifts in the clinical workforce.
A Chance to Reflect and Look Forward
Highlighting a year of conference coverage for ACT.
Relationships in the Current Landscape
How important are relationships when it comes to efficiently managing clinical trials?
Bringing Solutions Together
How does all of industry's newest technology fit together?
Staying Ahead of the Game
MJH Life Sciences, parent company of Applied Clinical Trials, continues to offer many forms of educational content to healthcare professionals.
'Audit-proofing' Your Trials
Increased adoption of decentralized trials and new advancements in technology among reasons for evolving regulatory landscape.
ASCO, Clinical Trials for Life
A look at the clinical trials side of oncology.